Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

June 28, 2023Research Article

Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease

View ORCID ProfileGabrielle A Donlevy, Kayla MD Cornett, View ORCID ProfileSarah P Garnett, Rosemary Shy, Timothy Estilow, View ORCID ProfileSabrina W Yum, Kimberly Anderson, View ORCID ProfileDavide Pareyson, Isabella Moroni, View ORCID ProfileFrancesco Muntoni, Mary M. Reilly, View ORCID ProfileRichard S. Finkel, View ORCID ProfileDavid N Herrmann, Katy J Eichinger, View ORCID ProfileMichael E Shy, View ORCID ProfileJoshua Burns, View ORCID ProfileManoj P. Menezes
First published June 28, 2023, DOI: https://doi.org/10.1212/WNL.0000000000207488
Gabrielle A Donlevy
1University of Sydney, Faculty of Medicine and Health & Children’s Hospital at Westmead, Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabrielle A Donlevy
  • For correspondence: gabrielle.donlevy@sydney.edu.au
Kayla MD Cornett
1University of Sydney, Faculty of Medicine and Health & Children’s Hospital at Westmead, Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah P Garnett
1University of Sydney, Faculty of Medicine and Health & Children’s Hospital at Westmead, Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah P Garnett
Rosemary Shy
2Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Estilow
3Department of Pediatrics, Carver College of Medicine; Division of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
4Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina W Yum
3Department of Pediatrics, Carver College of Medicine; Division of Neurology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
4Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sabrina W Yum
Kimberly Anderson
5Department of Occupational Therapy, Children's Hospital of Philadelphia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Davide Pareyson
6Fondazione IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Davide Pareyson
Isabella Moroni
6Fondazione IRCCS, Istituto Neurologico Carlo Besta, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Muntoni
7University College London Institute of Child Health & Great Ormond Street Hospital, London, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Francesco Muntoni
Mary M. Reilly
8Department of Neuromuscular Diseases, University College London Institute of Neurology, Queen Square, London, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard S. Finkel
9Center for Experimental Neurotherapeutics (Pediatrics), St. Jude Children's Research Hospital, Memphis, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard S. Finkel
David N Herrmann
10Department of Neurology, University of Rochester, Rochester, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David N Herrmann
Katy J Eichinger
11Department of Neurology, University of Rochester, Rochester, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E Shy
12Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael E Shy
Joshua Burns
1University of Sydney, Faculty of Medicine and Health & Children’s Hospital at Westmead, Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua Burns
Manoj P. Menezes
1University of Sydney, Faculty of Medicine and Health & Children’s Hospital at Westmead, Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manoj P. Menezes
Full PDF
Citation
Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease
Gabrielle A Donlevy, Kayla MD Cornett, Sarah P Garnett, Rosemary Shy, Timothy Estilow, Sabrina W Yum, Kimberly Anderson, Davide Pareyson, Isabella Moroni, Francesco Muntoni, Mary M. Reilly, Richard S. Finkel, David N Herrmann, Katy J Eichinger, Michael E Shy, Joshua Burns, Manoj P. Menezes
Neurology Jun 2023, 10.1212/WNL.0000000000207488; DOI: 10.1212/WNL.0000000000207488

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
8

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: The study aim was to evaluate the impact of body mass index (BMI) on disease progression over 2-years in children with Charcot-Marie-Tooth disease (CMT). Methods: BMI was classified in 242 participants 3-20 years with CMT enrolled in the Inherited Neuropathy Consortium, using the International Obesity Task Force (based on adult BMI values, kg/m2). Groups were categorised as severely underweight (BMI<17kg/m2), underweight (BMI≥17kg/m2 to <18.5kg/m2), healthy weight (BMI≥18.5kg/m2 to <25kg/m2), overweight (BMI≥25 kg/m2 to <30 kg/m2) and obese (BMI≥30kg/m2). Disease severity was assessed using the CMT Pediatric Scale (CMTPedS), a clinical outcome assessment of disability (0-44 points, mild-severe).

Results: At baseline, compared to being healthy weight (mean CMTPedS 15.48, SD 9.22), children who were severely underweight (mean CMTPedS difference 9.03, 95%CI 0.94-17.12; p=0.02,), underweight (mean CMTPedS difference 5.97, 95%CI 0.62-11.31; p=0.02), or obese (mean CMTPedS difference 7.96, 95%CI 1.03-14.88; p=0.015) exhibited greater disability. At 2-years, compared to being healthy weight (mean CMTPedS 17.53, SD 9.41), children who were severely underweight exhibited greater disability (mean CMTPedS difference 9.27, 95%CI 0.90-17.64; p=0.02). Over the 2-year periods, mean CMTPedS for the whole sample deteriorated by 1.72 points (95%CI 1.09-2.38; p<0.001), with severely underweight children progressing at the fastest rate (mean CMTPedS change of 2.3, 95%CI 1.53 – 6.13; p=0.21). In children who did not change BMI categories over 2-years (69% of sample), CMTPedS scores deteriorated faster in those who were severely underweight (mean CMTPedS change 6.40 points 95%CI 2.42 -10.38; p=0.01) than those of a healthy weight (mean CMTPedS change 1.79 points 95%CI 0.93 - 2.69; p<0.001). For children who changed BMI categories (31% of sample), CMTPedS scores deteriorated faster in children who became overweight/obese (mean CMTPedS change 2.76 points 95%CI 0.11 - 5.41; p=0.031).

Conclusion: Children with CMT who severely underweight, underweight, or obese exhibited greater disability at baseline. Over the 2-year period in those whose BMI remained stable, severely underweight children deteriorated at the fastest rate. For children who changed BMI categories over the 2 years, CMTPedS scores deteriorated faster in children who became overweight/obese. Interventions that maintain or improve BMI towards a healthy weight may reduce disability in children with CMT.

  • Received September 14, 2022.
  • Accepted in final form April 20, 2023.
  • © 2023 American Academy of Neurology Unauthorized reproduction of this article is prohibited

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease

Dr. Marianne de Visser and Dr. Maudy Theunissen

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Pediatric
  • All Neuromuscular Disease
  • Peripheral neuropathy

Alert Me

  • Alert me when eletters are published
Neurology: 101 (1)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise